DNA Methyltransferase Gene Polymorphisms for Prediction of Radiation-Induced Skin Fibrosis after Treatment of Breast Cancer: A Multifactorial Genetic Approach
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose This study was conducted to investigate the role of four polymorphic variants of DNA methyltransferase genes as risk factors for radiation-induced fibrosis in breast cancer patients. We also assessed their ability to improve prediction accuracy when combined with mitochondrial haplogroup H, which we previously found to be independently associated with a lower hazard of radiation-induced fibrosis. Materials and Methods DNMT1 rs2228611, DNMT3A rs1550117, DNMT3A rs7581217, and DNMT3B rs2424908 were genotyped by real-time polymerase chain reaction in 286 Italian breast cancer patients who received radiotherapy after breast conserving surgery. Subcutaneous fibrosis was scored according to the Late Effects of Normal Tissue–Subjective Objective Management Analytical (LENT-SOMA) scale. The discriminative accuracy of genetic models was assessed by the area under the receiver operating characteristic curves (AUC). Results Kaplan-Meier curves showed significant differences among DNMT1 rs2228611 genotypes in the cumulative incidence of grade 2 subcutaneous fibrosis (log-rank test p-value= 0.018). Multivariate Cox regression analysis revealed DNMT1 rs2228611 as an independent protective factor for moderate to severe radiation-induced fibrosis (GG vs. AA; hazard ratio, 0.26; 95% confidence interval [CI], 0.10 to 0.71; p=0.009). Adding DNMT1 rs2228611 to haplogroup H increased the discrimination accuracy (AUC) of the model from 0.595 (95% CI, 0.536 to 0.653) to 0.655 (95% CI, 0.597 to 0.710). Conclusion DNMT1 rs2228611 may represent a determinant of radiation-induced fibrosis in breast cancer patients with promise for clinical usefulness in genetic-based predictive models.
Abstract
Purpose This study was conducted to investigate the role of four polymorphic variants of DNA methyltransferase genes as risk factors for radiation-induced fibrosis in breast cancer patients. We also assessed their ability to improve prediction accuracy when combined with mitochondrial haplogroup H, which we previously found to be independently associated with a lower hazard of radiation-induced fibrosis. Materials and Methods DNMT1 rs2228611, DNMT3A rs1550117, DNMT3A rs7581217, and DNMT3B rs2424908 were genotyped by real-time polymerase chain reaction in 286 Italian breast cancer patients who received radiotherapy after breast conserving surgery. Subcutaneous fibrosis was scored according to the Late Effects of Normal Tissue–Subjective Objective Management Analytical (LENT-SOMA) scale. The discriminative accuracy of genetic models was assessed by the area under the receiver operating characteristic curves (AUC). Results Kaplan-Meier curves showed significant differences among DNMT1 rs2228611 genotypes in the cumulative incidence of grade 2 subcutaneous fibrosis (log-rank test p-value= 0.018). Multivariate Cox regression analysis revealed DNMT1 rs2228611 as an independent protective factor for moderate to severe radiation-induced fibrosis (GG vs. AA; hazard ratio, 0.26; 95% confidence interval [CI], 0.10 to 0.71; p=0.009). Adding DNMT1 rs2228611 to haplogroup H increased the discrimination accuracy (AUC) of the model from 0.595 (95% CI, 0.536 to 0.653) to 0.655 (95% CI, 0.597 to 0.710). Conclusion DNMT1 rs2228611 may represent a determinant of radiation-induced fibrosis in breast cancer patients with promise for clinical usefulness in genetic-based predictive models.
참고문헌 (29)
- Smith IE, "Breast radiotherapy after lumpectomy : no longer always necessary", N Engl J Med, 351, pp.1021~1023 (2004)
- O’Sullivan B, "Late radiation-related fibrosis : pathogenesis, manifestations, and current management", Semin Radiat Oncol, 13, pp.274~289 (2003)
- Barnett GC, "Normal tissue reactions to radiotherapy : towards tailoring treatment dose by genotype", Nat Rev Cancer, 9, pp.134~142 (2009)
- Deantonio L, "Hypofractionated radiotherapy after conservative surgery for breast cancer : analysis of acute and late toxicity", Radiat Oncol, 5, pp.112~ (2010)
- Lilla C, "Predictive factors for late normal tissue complications following radiotherapy for breast cancer", Breast Cancer Res Treat, 106, pp.143~150 (2007)
- Popanda O, "Genetic variation in normal tissue toxicity induced by ionizing radiation", Mutat Res, 667, pp.58~69 (2009)
- Barnett GC, "A genome wide association study(GWAS)providing evidence of an association between common genetic variants and late radiotherapy toxicity", Radiother Oncol, 111, pp.178~185 (2014)
- Robertson KD, "DNA methylation, methyltransferases, and cancer", Oncogene, 20, pp.3139~3155 (2001)
- Hackett JA, "DNA methylation dynamics during the mammalian life cycle", Philos Trans R Soc Lond B Biol Sci, 368, pp.20110328~ (2013)
- Lister R, "Human DNA methylomes at base resolution show widespread epigenomic differences", Nature, 462, pp.315~322 (2009)
- Neary R, "Epigenetics and the overhealing wound : the role of DNA methylation in fibrosis", Fibrogenesis Tissue Repair, 8, pp.18~ (2015)
- Weigel C, "Epigenetics in radiation-induced fibrosis", Oncogene, 34, pp.2145~2155 (2015)
- Antwih DA, "Radiation-induced epigenetic DNA methylation modification of radiation-response pathways", Epigenetics, 8, pp.839~848 (2013)
- Richardson RB, "Mitochondrial stress controls the radiosensitivity of the oxygen effect : implications for radiotherapy", Oncotarget, 7, pp.21469~21483 (2016)
- Atilano SR, "Mitochondrial DNA variants can mediate methylation status of inflammation, angiogenesis and signaling genes", Hum Mol Genet, 24, pp.4491~4503 (2015)
- Bellizzi D, "Global DNA methylation levels are modulated by mitochondrial DNA variants", Epigenomics, 4, pp.17~27 (2012)
- Seibold P, "XRCC1 polymorphism associated with late toxicity after radiation therapy in breast cancer patients", Int J Radiat Oncol Biol Phys, 92, pp.1084~1092 (2015)
- Terrazzino S, "Common European mitochondrial haplogroups in the risk for radiation-induced subcutaneous fibrosis in breast cancer patients", Clin Oncol(R Coll Radiol), 28, pp.365~372 (2016)
- Pavy JJ, "EORTC Late Effects Working Group. Late effects toxicity scoring: the SOMA scale", Int J Radiat Oncol Biol Phys, 31, pp.1043~1047 (1995)
- Andreassen CN, "A simulated SNP experiment indicates a high risk of over-fitting and false positive results when a predictive multiple SNP model is established and tested within the same dataset", Radiother Oncol, 114, pp.310~313 (2015)
- DeLong ER, "Comparing the areas under two or more correlated receiver operating characteristic curves : a nonparametric approach", Biometrics, 44, pp.837~845 (1988)
- Pouliot MC, "The role of methylation in breast cancer susceptibility and treatment", Anticancer Res, 35, pp.4569~4574 (2015)
- Saradalekshmi KR, "DNA methyl transferase (DNMT) gene polymorphisms could be a primary event in epigenetic susceptibility to schizophrenia", PLoS One, 9, pp.e98182~ (2014)
- Zhang W, "Genetic polymorphism of DNA methyltransferase 3A rs1550117 A>G and risk of cancer : a meta-analysis", J Invest Surg, 28, pp.346~353 (2015)
- Duan F, "Systematic evaluation of cancer risk associated with DNMT3B polymorphisms", J Cancer Res Clin Oncol, 141, pp.1205~1220 (2015)
- Mostowska A, "DNMT1, DNMT3A and DNMT3B gene variants in relation to ovarian cancer risk in the Polish population", Mol Biol Rep, 40, pp.4893~4899 (2013)
- Hossain MB, "Low-level environmental cadmium exposure is associated with DNA hypomethylation in Argentinean women", Environ Health Perspect, 120, pp.879~884 (2012)
- Martinez-Redondo D, "Human mitochondrial haplogroup H: the highest VO2max consumer: is it a paradox", Mitochondrion, 10, pp.102~107 (2010)
- Zhang QQ, "TET3mediates the activation of human hepatic stellate cells via modulating the expression of long non-coding RNA HIF1AAS1", Int J Clin Exp Pathol, 7, pp.7744~7751 (2014)